Monthly Archives: November 2008

Eye Divergence Triples Mental Illness Risk

Children whose eyes are misaligned and point outward are at significantly increased risk of developing mental illness by early adulthood, according to findings of a Mayo Clinic study published this month in Pediatrics, the official journal of the American Academy of Pediatrics.
The retrospective study examined the medical records of 407 patients with strabismus and [...]

Are You Having a Stroke? Many Don’t Know the Signs or Seek Treatment

A new study from Mayo Clinic shows that many people experiencing a stroke have no idea they’re having one, mainly because they don’t know the symptoms of stroke. Though stroke is very common, people are much less aware of the signs compared to those of a heart attack, even though stroke can be just as [...]

Alcoholic Hepatitis: Abstinence is Still the Best Policy

A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol.  Alcoholic hepatitis is a major cause of morbidity and mortality worldwide. Severe alcohol-related liver disease carries a poor prognosis. Several research studies have worked [...]

ALS Growth Hormone Study

A new study led by Mayo Clinic found that a growth hormone, IGF-1, showed no benefit for patients with ALS. The study included 330 people from 20 different medical centers. Two previous studies of the growth hormone had conflicting results. Eric Sorenson, M.D., a Mayo Clinic neurologist, was the lead author of this study.
ALS causes degeneration of the [...]

Potential New Therapy to Stop Progression of Parkinson’s Disease

Mayo Clinic researchers have developed a method to reduce the production of alpha-synuclein in the brain. Alpha-synuclein is a protein that is believed to be central to the cause of Parkinson’s disease. All patients with Parkinson’s disease have abnormal accumulations of alpha-synuclein protein in the brain.
The new method involves the delivery of RNA interference compounds [...]